Market Cap 27.49M
Revenue (ttm) 0.00
Net Income (ttm) -12.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 42,025
Avg Vol 522,642
Day's Range N/A - N/A
Shares Out 8.87M
Stochastic %K 7%
Beta 0.71
Analysts Strong Sell
Price Target $11.00

Latest News on ATHE

Alterity Therapeutics Raises A$40.0 million in Placement

Feb 10, 2025, 7:25 AM EST - 7 weeks ago

Alterity Therapeutics Raises A$40.0 million in Placement


Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

Jan 24, 2025, 7:35 AM EST - 2 months ago

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report


Appendix 4C – Q1 FY25 Quarterly Cash Flow Report

Oct 31, 2024, 7:35 AM EDT - 5 months ago

Appendix 4C – Q1 FY25 Quarterly Cash Flow Report


Appendix 4C – Q4 FY24 Quarterly Cash Flow Report

Jul 31, 2024, 7:35 AM EDT - 8 months ago

Appendix 4C – Q4 FY24 Quarterly Cash Flow Report


Alterity Therapeutics to Present at MST Financial Webinar

Jul 24, 2024, 7:35 AM EDT - 9 months ago

Alterity Therapeutics to Present at MST Financial Webinar


Appendix 4C – Q3 FY24 Quarterly Cash Flow Report

Apr 30, 2024, 7:25 AM EDT - 1 year ago

Appendix 4C – Q3 FY24 Quarterly Cash Flow Report


Appendix 4C – Q1 FY24 Quarterly Cash Flow Report

Oct 30, 2023, 7:25 AM EDT - 1 year ago

Appendix 4C – Q1 FY24 Quarterly Cash Flow Report


Appendix 4C – Q4 FY23 Quarterly Cash Flow Report

Jul 31, 2023, 7:52 AM EDT - 1 year ago

Appendix 4C – Q4 FY23 Quarterly Cash Flow Report


Appendix 4C – Q3 FY23 Quarterly Cash Flow Report

May 10, 2023, 7:25 AM EDT - 2 years ago

Appendix 4C – Q3 FY23 Quarterly Cash Flow Report